Proliferation of Novel Cell Type Platforms in the Oncology Competitive Landscape – PART I (White Paper)

The objective…is to help elucidate the complex biology and positioning strategy being brought to bear in the capital-intensive but opportunity-laden endeavor of advancing novel cancer therapies to market. We provide brief snapshots of different cell types, their potential promise as therapeutic platforms, and the companies developing them.